CN1824036A - Chinese medicinal composition for treating hemilateral headache and its preparation method - Google Patents

Chinese medicinal composition for treating hemilateral headache and its preparation method Download PDF

Info

Publication number
CN1824036A
CN1824036A CN 200510033265 CN200510033265A CN1824036A CN 1824036 A CN1824036 A CN 1824036A CN 200510033265 CN200510033265 CN 200510033265 CN 200510033265 A CN200510033265 A CN 200510033265A CN 1824036 A CN1824036 A CN 1824036A
Authority
CN
China
Prior art keywords
green tea
preparation
alcohol
chinese medicine
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510033265
Other languages
Chinese (zh)
Other versions
CN100486621C (en
Inventor
吴智南
黄能章
招翠微
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Huahai Pharmaceutical Co., Ltd.
Original Assignee
Guangzhou Guzhi Medicine Sci-Tech Develoment Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Guzhi Medicine Sci-Tech Develoment Co Ltd filed Critical Guangzhou Guzhi Medicine Sci-Tech Develoment Co Ltd
Priority to CNB2005100332652A priority Critical patent/CN100486621C/en
Publication of CN1824036A publication Critical patent/CN1824036A/en
Application granted granted Critical
Publication of CN100486621C publication Critical patent/CN100486621C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in the form of tablet for treating hemicrania, eyebrow bone pain and prosopantritis is proportionally prepared from dahurian angelica root, Chuan-xiong rhizome and green tea through thermal reflux in alcohol, filtering and concentrating for the first two, decocting and filtering for green tea, mixing, concentrating, adding beta-dextrin, stirring, vacuum drying, pulverizing, adding additive, granulating and tabletting.

Description

Migrainous Chinese medicine composition of a kind of treatment and preparation method thereof
Technical field
The present invention relates to the migrainous medicine of a kind of treatment, be meant the migrainous Chinese medicine composition of a kind of treatment especially, the invention still further relates to the preparation method of this Chinese medicine composition.
Background technology
Migraine is a kind of the most common clinically vascular headache, is head vasomotor dysfunction and cerebral cortex functional disorder, or the caused clinical syndrome of the temporary change of some humoral substance.Migraine is the periodical attack disease that a class has family's morbidity tendency, shows as the inclined to one side side pulsatile headache of paroxysmal outbreak, and the companion feels sick, vomiting machine photophobia, can be with nerve, moral function obstacle before headache takes place or during outbreak.Migraine is a common frdquently encountered disease, and is mainly in adolescence (sickness rate was the highest in 20~29 years old).In recent years, along with the progress of society and the raising of people's living standard, the change of dietary structure, the quickening of work and study rhythm and the pollution of air ambient are suffered from migrainous patient day and are more increased.According to relevant bibliographical information, it is about 9% that the average attack rate male of this disease in the various countries crowd is grown up, and the women is grown up about 16%.Domestic sickness rate is then higher, and the inland north sickness rate in summer is up to 55.3%, and southern area is wet partially warm spring, and spring, sickness rate was also high to 46.3%.Morbidity women's ratio is higher than the male, and men and women's ratio is 1: 3.5, and the aeg falls ill normal relevant with menstruation.Owing to have the above-mentioned symptom during except that morbidity, outbreak back most of patients has tired, drowsy, has seriously hindered patient's work and study and rest.Migrainous control comes into one's own day by day.
At present, doctor trained in Western medicine still fails to illustrate fully to the cause of disease of primary disease, the treatment migraine still lacks ideal medicine, and the traditional Chinese medical science is to this sick existing comparatively mature theory basis and clinical treatment experience, so the migrainous medicine of treatment by Chinese herbs has good development prospect, current main medicine is: kinds such as the six channels headache tablets, rhizoma gastrodiae tablets for relieving headache, armillaria mellea accreting with Rhizoma Gastrodiae sheet, wind syndrome of head pain ball, and less for the Chinese patent medicine kind of selection of clinical.Because of migrainous common property, multiple, need regular medication treatment, again so the huge market demand of this quasi drugs.Adopt the migrainous effect of wind syndrome of head pain pill for curing better clinically, its prescription is as follows with preparation method: [prescription] Radix Angelicae Dahuricae 420g, Rhizoma Chuanxiong 60g, green tea 30g.[method for making] above three flavors are ground into fine powder, sieve, and mixing is used water pill, dries or cold drying, promptly.[usage and consumption] is oral, a 6~9g, 2 times on the one.According to Chinese medical discrimination, the card that this side controlled, be because of venation numbness resistance jerk urgency or muscle arteries and veins lose support due to, and many with the liver failing to maintain the normal flow of QI, hold under the arm disturb on the heresy relevant.Excessive rising of liver-YANG, then headache and bloated, dizzy bitter taste, dysphoria with feverish sensation in the chest palms and soles; Disturb on expectorant is turbid, the unconsciousness of then having a headache, chest distress, the heavy body of limb is tired; Control suitable wind-expelling pain-stopping, promoting flow of QI and blood.Be monarch with the Radix Angelicae Dahuricae in the side, its acrid in the mouth is warm in nature, kind expelling wind and removing dampness, understand things pain-stopping.The Rhizoma Chuanxiong acrid in the mouth is warm in nature, the function promoting blood circulation to remove blood stasis, and activating QI to alleviate the depression has the merit of diffusing wind pain relieving, is the key medicine for the treatment of blood disorders.The same usefulness of two medicines, dispelling wind looses evil, and the expectorant stasis of blood is ruled together.Green tea bitter in the mouth, sweet cool in nature is aided with the refresh oneself, and relieving restlessness is reduced phlegm; All medicines match, and the ailment said due to cold or exposure of the five internal organs is all dispelled, and stagnation of QI blood stasis removes to the greatest extent.
But the former dosage form of wind syndrome of head pain ball is the watered pill, the medical material un-extracted, bioavailability is low and dose big, and (one time 6~9g), former dosage form quality standard has only the physicochemical identification of coumarin substances in the microscopical identification and the Radix Angelicae Dahuricae, far can not reach present requirement to drug standard.The present inventor is through to this side's conscientiously research, and the dosage form that exploitation makes new advances at the safety that guarantees medicament and effectiveness simultaneously, strengthens the bioavailability of material medicine, so that its drug effect is higher, dose reduces, carries, use, accumulating be more convenient.
Summary of the invention
One of them purpose of the present invention be to provide a kind of medical material bioavailability height, good drug efficacy, carry, the migrainous Chinese medicine composition of a kind of treatment of taking convenience.
Another object of the present invention is to provide a kind of method for preparing this Chinese medicine composition.
Last purpose of the present invention is achieved in that the migrainous Chinese medicine composition of a kind of treatment, is to be made by the alcohol extract of 42 parts of Radixs Angelicae Dahuricae, 6 parts of Rhizoma Chuanxiongs and the water extract and the convas tablet adjuvant of 3 portions of green tea, and above-mentioned deal is a weight portion.
Back of the present invention one purpose is achieved in that a kind of preparation method for the treatment of migrainous Chinese medicine composition, comprises the steps:
A) take by weighing the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, green tea by weight, standby;
B) Radix Angelicae Dahuricae, Rhizoma Chuanxiong are extracted secondary with alcohol heating reflux, filter, filtrate is condensed into the concentrated solution 1 that does not have the alcohol flavor, and is standby;
C) green tea is decocted with water 1.5 hours, filter to get filtrate 2;
D) above-mentioned concentrated solution 1 and filtrate 2 are merged, concentrating under reduced pressure, the adding powder-beta-dextrin is an amount of, stirs, and pulverizes behind the vacuum drying, adds right amount of auxiliary materials, makes granule, and compacting is in flakes.
Be adopted as 60%~80% ethanol extraction in the step b) in above-mentioned a kind of preparation method for the treatment of migrainous Chinese medicine composition, add 6 times of amount ethanol for the first time, heating and refluxing extraction 2 hours adds 5 times of amount ethanol for the second time, heating and refluxing extraction 2 hours.
The present invention extracts, makes with extra care by the effective ingredient to raw medicinal material, not only can improve the bioavailability of raw medicinal material, better bring into play drug effect, preparation technology, the easier control of product quality, and can reduce each dose greatly, made things convenient for taking, carrying of patient.By the drug effect that preparation of the present invention is correlated with, the experimental study of toxicity, the result shows that this product is compared with former pill, and drug effect is stronger, and does not see toxic reaction.
The specific embodiment
The preparation of embodiment 1 Chinese medicine composition of the present invention
A) take by weighing Radix Angelicae Dahuricae 2471g, Rhizoma Chuanxiong 353g, green tea 176g by weight, standby;
B) Radix Angelicae Dahuricae, Rhizoma Chuanxiong are extracted secondary with 70% alcohol heating reflux, add 6 times of amount ethanol for the first time, heating and refluxing extraction 2 hours adds 5 times of amount ethanol for the second time, heating and refluxing extraction 2 hours; Filter, filtrate is condensed into the concentrated solution 1 that does not have the alcohol flavor, and is standby;
C) green tea is added an amount of decocting and boiled 1.5 hours, filter to get filtrate 2;
D) above-mentioned concentrated solution 1 and filtrate 2 are merged, concentrating under reduced pressure, the adding powder-beta-dextrin is an amount of, stirs, and pulverizes behind the vacuum drying, adds right amount of auxiliary materials, makes granule, is pressed into 1000 tablets of tablets.
The usage of above-mentioned tablet and consumption: oral, one time 2~3,2 times on the one.
The influence of experimental example 1 concentration of alcohol to extracting
Experimental technique: get (recipe quantity 1/10) medical material with lot number, Rhizoma Chuanxiong 35.3g, Radix Angelicae Dahuricae 247.1g (containing imperatorin 0.62mg/g, isoimperatorin 0.53mg/g) are one group, respectively get 5 groups, all be processed into the following segment of 1cm, each adds 9 (5,4) times Different concentrations of alcohol (50%, 60%, 70%, 80%, 90%), reflux respectively 2 times, each 1.5 hours, merge, filter, the content of sampling and measuring imperatorin, isoimperatorin and measure its solid content, and calculate its yield, experimental result sees Table 1:
Table 1
The experiment sequence number 1 2 3 4 5
Concentration of alcohol (%) 50 60 70 80 90
Dry extract yield (%) 17.10 14.69 13.41 11.72 8.46
The peucedanin rate of transform (%) 70.94 90.70 97.99 96.31 87.60
Show from above-mentioned experimental result: along with the corresponding minimizing of yield of the increase extractum of concentration of alcohol, concentration of alcohol is greater than after 80%, and the rate of transform of peucedanin obviously reduces, and therefore, preferred alcohol concentration is 60%~80%.
Experimental example 2 effect experiments
For observing the antiinflammatory of Chinese medicine composition of the present invention, analgesia, effect such as microcirculation improvement and antiplatelet aggregation, utilization mice caused by dimethylbenzene xylene capillary of skin permeability increases test, carrageenin causes the rat paw edema test, the test of mice caused by dimethylbenzene xylene auricle edema, rat granuloma is tested by swollen formation, acetic acid causes the test of mice pain writhing response, light radiation causes the rat tail-flick test, hot plate causes the pain test, microcirculation of mouse auricle is influenced, to the experiments such as influence of rat platelet aggregation, observe its antiinflammatory, analgesia, effect such as microcirculation improvement and antiplatelet aggregation.Found that Chinese medicine composition xylol of the present invention causes that the mouse skin capillary permeability increases, on Carrageenan causes rat paw edema, mice caused by dimethylbenzene xylene auricle edema, rat granuloma swollenly form, acetic acid causes mice pain writhing response, light radiation causes the rat whipping etc. all has obvious inhibitory action, significantly improve the Mice Auricle microcirculation, improve effects such as antiplatelet aggregation.
Experimental example 3 acute toxicity testings
Mouse stomach is administered twice within one day, the accumulative total dosage is 31.2g dry extract/kg body weight, be equivalent to contain 187.2g crude drug/kg body weight, observed for 2 weeks continuously behind the medicine, do not find dead mouse and tangible toxicity, the maximum tolerated dose of Chinese medicine composition of the present invention is 31.2g dry extract/kg, is equivalent to the clinical plan of people with dosage (624 times of 0.05g dry extract/kg/d).
Experimental example 4 long term toxicity tests
Rat continuous irrigation stomach gives Chinese medicine composition tablet of the present invention (3.00,1.50 and 0.75g dry extract/kg body weight) 3 months, and experimental result shows that rat growthing development (body weight) and general behavior are not had obvious influence; Hematological indices such as hemoglobin, erythrocyte, numeration of leukocyte and classification, clotting time etc. are not all made significant difference; Blood glucose, liver function and renal function to blood biochemistry checking do not have obvious influence; Histopathological examination shows that the heart, liver, spleen, lung, kidney, adrenal gland, thymus, thyroid are not had the obvious damage effect.The above results shows Chinese medicine composition of the present invention, and application safety is reliable within a certain period of time, can not produce tangible toxic action.

Claims (3)

1. the migrainous Chinese medicine composition of treatment is to be made by the alcohol extract of 42 parts of Radixs Angelicae Dahuricae, 6 parts of Rhizoma Chuanxiongs and the water extract and the convas tablet adjuvant of 3 portions of green tea, and above-mentioned deal is a weight portion.
2. the described a kind of preparation method for the treatment of migrainous Chinese medicine composition of claim 1, its feature comprises the steps:
A) take by weighing the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, green tea by weight, standby;
B) Radix Angelicae Dahuricae, Rhizoma Chuanxiong are extracted secondary with alcohol heating reflux, filter, filtrate is condensed into the concentrated solution 1 that does not have the alcohol flavor, and is standby;
C) green tea is decocted with water 1.5 hours, filter to get filtrate 2;
D) above-mentioned concentrated solution 1 and filtrate 2 are merged, concentrating under reduced pressure, the adding powder-beta-dextrin is an amount of, stirs, and pulverizes behind the vacuum drying, adds right amount of auxiliary materials, makes granule, and compacting is in flakes.
3. preparation method according to claim 2 is characterized in that employing 60%~80% ethanol extraction in the step b), adds 6 times of amount ethanol for the first time, and heating and refluxing extraction 2 hours adds 5 times of amount ethanol for the second time, heating and refluxing extraction 2 hours.
CNB2005100332652A 2005-02-23 2005-02-23 Chinese medicinal composition for treating hemilateral headache and its preparation method Expired - Fee Related CN100486621C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100332652A CN100486621C (en) 2005-02-23 2005-02-23 Chinese medicinal composition for treating hemilateral headache and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100332652A CN100486621C (en) 2005-02-23 2005-02-23 Chinese medicinal composition for treating hemilateral headache and its preparation method

Publications (2)

Publication Number Publication Date
CN1824036A true CN1824036A (en) 2006-08-30
CN100486621C CN100486621C (en) 2009-05-13

Family

ID=36934976

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100332652A Expired - Fee Related CN100486621C (en) 2005-02-23 2005-02-23 Chinese medicinal composition for treating hemilateral headache and its preparation method

Country Status (1)

Country Link
CN (1) CN100486621C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102145132A (en) * 2011-03-13 2011-08-10 刘秀娥 Traditional Chinese medicine for treating forehead pain
CN104740094A (en) * 2015-04-07 2015-07-01 河南中医学院 Traditional Chinese medicine for treating migraine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102145132A (en) * 2011-03-13 2011-08-10 刘秀娥 Traditional Chinese medicine for treating forehead pain
CN104740094A (en) * 2015-04-07 2015-07-01 河南中医学院 Traditional Chinese medicine for treating migraine

Also Published As

Publication number Publication date
CN100486621C (en) 2009-05-13

Similar Documents

Publication Publication Date Title
CN1742939B (en) Medicine for treating pulmonary fibrosis and preparing method
CN101700275A (en) Pharmaceutical preparation containing axillary choerospondias fruit and preparation method and application thereof
CN100486621C (en) Chinese medicinal composition for treating hemilateral headache and its preparation method
CN1255170C (en) Cough-relieving bagged tea and its prepn
CN105434738A (en) Traditional Chinese medicine composition for treating ADHD (Attention Deficit Hyperactivity Disorder) and preparation method thereof
CN102430039B (en) Traditional Chinese medicinal composition for treating diabetes mellitus and preparation method thereof
CN102274394A (en) Chinese medicinal composition for treating postnatal constipation
CN1745809A (en) Liuwei Dihuang effervescent tablet and its preparation thereof
CN115531458A (en) Application of traditional Chinese medicine composition in preparation of medicine for preventing or treating arrhythmia
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN108186821B (en) Traditional Chinese medicine composition for treating nervous headache and preparation method and application thereof
CN104095940B (en) A kind of Chinese medicine composition for the treatment of gout
CN103110100A (en) Korean medical healthcare food composition as well as preparation method and application thereof
CN102120000B (en) Composition of effective parts of traditional Chinese medicine preparation for resisting Coxsackie virus B and preparation method thereof
CN102949681B (en) Composition for preventing or treating colds, and its preparation method
CN102225082B (en) Medicament for preventing and treating diabetes and complications thereof and preparation method thereof
CN105664102A (en) Traditional Chinese medicine composition for improving immunity
CN104436022A (en) Hemsleya-macrosperma-containing traditional Chinese medicine composition for treating diabetes mellitus
CN1827138A (en) Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof
CN104352672A (en) Tortoise plastron-containing traditional Chinese medicine composition for treating diabetes
CN104256618A (en) Food, health care product or medicine composition with blood sugar reduction function
CN104337898B (en) A kind of Chinese medicine composition of the treatment gout containing Semen Pruni
CN104352974A (en) Ciliatenerve knotweed root-containing traditional Chinese medicine composition for treating diabetes
CN105943860A (en) Medicine preparation for treating diabetes mellitus and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: GUZHI PHARMACEUTICAL SCIENCE CO., LTD., GUANGZHOU

Free format text: FORMER NAME: GUANGZHOU GUZHI PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.

CP03 Change of name, title or address

Address after: Six floor, No. 80 Guangzhou science and technology innovation base in C District of Guangdong city of Guangzhou province Luogang District Science City Guangzhou lanyue Road

Patentee after: Guzhi Medicine Tech Co., Ltd., Guangzhou

Address before: Tianhe District Shahe longan cave Guangdong medical school in Guangzhou, Guangdong

Patentee before: Guangzhou Guzhi Medicine Sci-Tech Develoment Co., Ltd.

C56 Change in the name or address of the patentee

Owner name: GUANGZHOU HUAHAI PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: GUZHI PHARMACEUTICAL SCIENCE CO., LTD., GUANGZHOU

CP03 Change of name, title or address

Address after: Moon City Road, Guangzhou economic and Technological Development Zone 510663 Guangdong province science and technology innovation base of Guangzhou No. 80 C District sixth floor

Patentee after: Guangzhou Huahai Pharmaceutical Co., Ltd.

Address before: Six floor, No. 80 Guangzhou science and technology innovation base of Guangdong Province, Guangzhou city C District 510630 Luogang District Science City Guangzhou lanyue Road

Patentee before: Guzhi Medicine Tech Co., Ltd., Guangzhou

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090513

Termination date: 20200223